Lactic Acidosis Risk Comparison
Introduction to Lactic Acidosis
- The American Journal of Kidney Diseases recommends that patients with renal impairment (eGFR <30 ml/min/1.73 m²) should avoid metformin due to the increased risk of lactic acidosis 3, 4
- The Lancet Diabetes and Endocrinology states that metformin can cause lactic acidosis, especially in patients with renal impairment or those undergoing major surgery, with a reported incidence rate of less than 1 per 100,000 patient-years 1
- Diabetes Care suggests that the risk of metformin-induced lactic acidosis is higher in patients with heart failure, hypoxemia, sepsis, or other conditions that may increase lactate production 5, 6
Patient Selection
- The American Journal of Kidney Diseases advises that metformin is contraindicated in patients with eGFR <30 ml/min/1.73 m² due to the high risk of lactic acidosis 3, 4
- Praxis Medical Insights recommends considering imeglimin as a safer alternative to metformin in patients with renal impairment or acute diseases, although long-term clinical experience is still limited 2
- The Lancet Diabetes and Endocrinology notes that imeglimin may have a lower risk of lactic acidosis compared to metformin, especially in patients with renal impairment or those undergoing major surgery 1